# Foghorn Therapeutics Inc. (FHTX) stock price

URL: https://funkfolio.com/stock/FHTX

> Foghorn Therapeutics Inc. (FHTX) trades at $1.83, is worth $109.73M, is priced at 20.3× earnings and scores 51/100. Valuation, financials and signals.

---

## Foghorn Therapeutics Inc. (FHTX)

Foghorn Therapeutics Inc. (FHTX) is a healthcare company (biotechnology) based in the United States. The share price is $1.83, up 2.23% on the day, which values the company at $109.73M. Price as of 18 Nov 2026, 12:48 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $1.83 +2.23% today
- **Market value:** $109.73M
- **P/E ratio:** 20.3× last 12 months
- **Funk Score:** 51/100
- **200-week average:** $5.52 67% below
- **Sector:** Healthcare

Figures as of 18 Nov 2026, 12:48 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Foghorn Therapeutics Inc. in more detail

FHTX trades at 20.3× its last twelve months' earnings, -1.6× next year's expected earnings, 1.0× sales. It sits 67% below its 200-week average of $5.52.

Over the last five fiscal years Foghorn Therapeutics Inc. has compounded revenue 135.1% a year. Its Funk Score is 51 out of 100 (financial strength 3.8, profitability 2.5, growth 8.9, each out of 10).

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

### Foghorn Therapeutics Inc. (FHTX): questions and answers

**What is FHTX's P/E ratio?**

Foghorn Therapeutics Inc. trades at 20.3× its last twelve months' earnings and -1.6× next year's expected earnings.

**What is Foghorn Therapeutics Inc.'s market cap?**

Foghorn Therapeutics Inc. is valued at $109.73M at a share price of $1.83.

**Is FHTX above its 200-week moving average?**

No. FHTX is 66.9% below its 200-week average of $5.52. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is Foghorn Therapeutics Inc. growing?**

Over the last five fiscal years Foghorn Therapeutics Inc.'s revenue grew 135.1% a year.

**Does FHTX pay a dividend?**

Foghorn Therapeutics Inc. does not currently pay a regular dividend.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Foghorn Therapeutics Inc. (FHTX) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/FHTX

Underlying data: Yahoo Finance; company filings with the SEC.
